Hormone Replacement Therapy

Introduction to hCG Therapy

The Journal of Clinical Oncology notes that LH can cross-react with some hCG assays, which may complicate laboratory monitoring 1

hCG therapy may cause symptoms of gynecomastia or breast tenderness, which may indicate excessive estradiol conversion, and the American Urological Association recommends monitoring testosterone and estradiol levels regularly 2
Using hCG when LH and FSH levels are normal may lead to disruption of the natural hormonal feedback system, potential supraphysiological testosterone levels, unnecessary medical costs, and risk of side effects without clinical benefit 3
Men with breast cancer should avoid treatments that could increase estrogen levels, such as clomiphene citrate, as recommended by the National Comprehensive Cancer Network 4

Serum testosterone, LH, FSH levels should be measured, and a testicular examination should be performed to assess size, consistency, and descent in men with suspected hypogonadism 2
Semen analysis should be considered to evaluate baseline spermatogenesis, and if severe oligospermia or azoospermia is present, genetic testing (karyotype, Y-chromosome microdeletion analysis) should be considered 2
hCG stimulation testing can be used to evaluate testicular function in specific scenarios, such as suspected anorchia, as noted by the American Urological Association 3

For Hypogonadotropic Hypogonadism (Low LH/FSH), first-line treatment is Selective Estrogen Receptor Modulators (SERMs) such as clomiphene citrate, which blocks estrogen receptors in the hypothalamus, increasing GnRH pulsatility and resulting in increased LH and FSH production and endogenous testosterone 2, 5, 6
Alternative treatment is Human Chorionic Gonadotropin (hCG), which mimics LH action, stimulates Leydig cells to produce testosterone, and requires monitoring of testosterone levels until normalization 5, 6
For Persistent FSH Deficiency After Testosterone Normalization, add recombinant FSH or human menopausal gonadotropin (hMG) to directly stimulate spermatogenesis 5, 6
Exogenous testosterone should not be prescribed to men interested in current or future fertility, as it can suppress the hypothalamic-pituitary-gonadal axis and impair spermatogenesis 5, 6
Clomiphene citrate is a treatment option for male hypogonadism, particularly for men who wish to preserve fertility, as recommended by the American Urological Association (AUA) 2, 6
Baseline estradiol levels should be measured before starting clomiphene citrate treatment, and estradiol levels should be monitored during treatment, particularly in men who develop breast symptoms, as recommended by the AUA 2
Men with pre-existing elevated estradiol should be referred to an endocrinologist before considering clomiphene citrate treatment, as recommended by the AUA 2

Testosterone levels should be measured every 4-6 weeks until normalized, and semen parameters should be assessed every 3 months 2, 6
Treatment should be continued until pregnancy is achieved or sperm parameters improve sufficiently for assisted reproductive technology (ART) 2, 6
Response to treatment correlates with testicular size prior to treatment, highlighting the importance of initial assessment 6

The American Urological Association recommends hCG for diagnostic testing to evaluate testicular function in specific scenarios, such as suspected anorchia 3
The American Urological Association notes that hCG has been historically used to induce testicular descent, though with limited long-term efficacy (success rates of 6-38% in controlled studies) 3
Clinicians should inform patients that selective estrogen receptor modulators (SERMs) like clomiphene have limited benefits for male idiopathic infertility relative to ART, with small benefits outweighed by advantages of medically-assisted reproduction 5
Consider ART options like IVF/ICSI if treatment fails 6
Concurrent use of clomiphene and finasteride during fertility treatment should be avoided, as finasteride interferes with androgenic pathways critical for spermatogenesis and can counteract the intended effects of clomiphene therapy 5
Topical minoxidil can be safely continued during clomiphene therapy, as it has minimal systemic absorption and does not significantly interfere with hormonal pathways involved in spermatogenesis 5
Finasteride should be discontinued at least 3 months before starting fertility treatment to allow for complete clearance of the drug and recovery of normal DHT levels 5